- Home
- PAI vs THTX Comparison
PAI vs THTX Comparison
Compare PAI & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAI
- THTX
- Stock Information
- Founded
- PAI 1973
- THTX 1993
- Country
- PAI United States
- THTX Canada
- Employees
- PAI N/A
- THTX N/A
- Industry
- PAI Trusts Except Educational Religious and Charitable
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- PAI Finance
- THTX Health Care
- Exchange
- PAI Nasdaq
- THTX Nasdaq
- Market Cap
- PAI 122.0M
- THTX 144.8M
- IPO Year
- PAI N/A
- THTX N/A
- Fundamental
- Price
- PAI $12.69
- THTX $3.26
- Analyst Decision
- PAI
- THTX Hold
- Analyst Count
- PAI 0
- THTX 1
- Target Price
- PAI N/A
- THTX N/A
- AVG Volume (30 Days)
- PAI 25.0K
- THTX 284.5K
- Earning Date
- PAI 01-01-0001
- THTX 10-09-2025
- Dividend Yield
- PAI 4.78%
- THTX N/A
- EPS Growth
- PAI N/A
- THTX N/A
- EPS
- PAI N/A
- THTX N/A
- Revenue
- PAI N/A
- THTX $84,378,000.00
- Revenue This Year
- PAI N/A
- THTX N/A
- Revenue Next Year
- PAI N/A
- THTX $13.76
- P/E Ratio
- PAI N/A
- THTX N/A
- Revenue Growth
- PAI N/A
- THTX 2.19
- 52 Week Low
- PAI $10.59
- THTX $1.12
- 52 Week High
- PAI $12.63
- THTX $3.26
- Technical
- Relative Strength Index (RSI)
- PAI 45.62
- THTX 74.59
- Support Level
- PAI $12.65
- THTX $3.18
- Resistance Level
- PAI $12.80
- THTX $3.22
- Average True Range (ATR)
- PAI 0.13
- THTX 0.02
- MACD
- PAI -0.01
- THTX -0.01
- Stochastic Oscillator
- PAI 34.37
- THTX 100.00
About PAI Western Asset Investment Grade Income Fund Inc.
Western Asset Investment Grade Income Fund Inc is a closed-end diversified investment company. The company designed as a long-term investment and not as a trading vehicle. The fund seeks a high level of current income, consistent with prudent investment risk, through investment in a diversified portfolio of debt securities. Its portfolio is invested in securities which may be convertible into or exchangeable for, or carry warrants to purchase, common stock or other equity interests; and preferred stock.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.